Yangwei Fan, Xuyuan Dong, Meichen Wang, Yu Shi, Ke Wang, Enxiao Li, Yinying Wu. "Liposomal irinotecan plus sintilimab and lenvatinib for second-line advanced HER2-negative gastric/gastro-esophageal junction adenocarcinoma: A phase II trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16035